TMCI - Treace Medical Concepts Inc

Healthcare - Sector

TMCI is currently covered by 4 analysts with average potential upside of $9.41 (48.51%) backed by 0 price targets and 15 ratings. Analyst's average stock valuation to be materialised ratio is 26.43% with an average time for price targets to be met of 36 days.

Most recent stock forecast was given by DREW RANIERI from MORGAN STANLEY on 11-Oct-2022.

Highest price target for TMCI is 36, Lowest price target is 14, average price target is 25.

Best performing analysts who are covering TMCI - Treace Medical Concepts Inc:

Andrew Ranieri Rick Wise Robbie Marcus Danielle Antalffy Ryan Zimmerman

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

28

$5.79 (26.07%)

23

1 months 16 days ago

4/7 (57.14%)

$5.27 (27.50%)

22

Buy

27

$4.79 (21.57%)

21

2 months 6 days ago

1/4 (25%)

$5.54 (28.23%)

38

Buy

28

$5.79 (26.07%)

22

2 months 6 days ago

1/2 (50%)

$6.73 (41.88%)

120

Buy

37

$14.79 (66.59%)

8 months 12 days ago

0/1 (0%)

$18.15 (96.29%)

Buy

32

$9.43 (41.78%)

38

1 years 15 days ago

0/5 (0%)

$11.36 (48.67%)

Show more analysts

This chart will make you best informed on how analysts see your stock and which of them does well in less than two minutes.

28 days free trial

We do our best to collect, sort, and check every available news item on your stocks so that you can focus on what is important

For each analyst know for every call if it has been before or after the stock price moved

Understand how each analyst reacts to stock price movement

Get Started or Login